Volume 17, Number 6—June 2011
CME ACTIVITY - Research
Taenia solium Tapeworm Infection, Oregon, 2006–2009
Seth E. O’Neal
, John Noh, Patricia P. Wilkins, William Keene, William Lambert, James Anderson, Jenifer Compton Luman, and John M. Townes
, John Noh, Patricia P. Wilkins, William Keene, William Lambert, James Anderson, Jenifer Compton Luman, and John M. Townes
Table 4
Demographic and clinical characteristics of case-patients with investigated and noninvestigated cysticercosis , Oregon, 2006–2009*
| Characteristic† | Eligible for household investigation |
No. (%) not eligible, n = 40 | p value‡ | |
|---|---|---|---|---|
| No. (%) investigated, n = 22 | No. (%) not Investigated, n = 10 | |||
| Male sex |
14 (64) |
9 (90) |
23 (58) |
0.16 |
| Lesions | ||||
| 1 | 6 (27) | 2 (20) | 14 (35) | 0.55 |
| >1 |
16 (73) |
8 (80) |
26 (65) |
|
| Lesion location | ||||
| Parenchymal | 17 (77) | 9 (90) | 35 (88) | 0.21 |
| Extraparenchymal | 2 (9) | 1 (10) | 0 | |
| Mixed |
3 (14) |
0 |
5 (13) |
|
| Lesion stage | ||||
| Cystic | 6 (27) | 1 (10) | 15 (38) | 0.15 |
| Calcified | 8 (36) | 8 (80) | 16 (40) | |
| Mixed |
8 (36) |
1 (10) |
9 (23) |
|
| EITB LLGP positive | 9 (41) | – | – | |
*EITB LLGP, enzyme-linked immunoelectrotransfer blot for antibodies against lentil lection–bound glycoprotein of Taenia solium cysts.
†Median age, y (interquartile range): investigated, 31 (28–37); not investigated, 42 (35–57); not eligible, 35 (25–43); p = 0.15 by Kruskal-Wallis χ2 test.
‡By Fisher exact test.
Page created: September 01, 2011
Page updated: September 01, 2011
Page reviewed: September 01, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.